Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$90.20−1.24 (-1.36%)
Close on Nov 12, 2026Market cap $7.08BP/E –Yield –
Abivax total assets
Total assets on the balance sheet at the end of each period.
Abivax's total assets was €462.21M at Jun 30, 2026. For fiscal 2025 it was €584.34M, up 184.7% from the year before. The highest annual figure on record is €584.34M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €584.34M | +184.7% |
| FY2024 | Dec 31, 2024 | €205.23M | -37.3% |
| FY2023 | Dec 31, 2023 | €327.06M | +332.9% |
| FY2022 | Dec 31, 2022 | €75.54M | -30.8% |
| FY2021 | Dec 31, 2021 | €109.23M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €462.21M | +286.3% |
| Q1 FY2026 | Mar 31, 2026 | €547.14M | +227.7% |
| Q4 FY2025 | Dec 31, 2025 | €584.34M | +184.7% |
| Q3 FY2025 | Sep 30, 2025 | €652.05M | +99.4% |
| Q2 FY2025 | Jun 30, 2025 | €119.64M | +58.4% |
| Q1 FY2025 | Mar 31, 2025 | €166.94M | +52.8% |
| Q4 FY2024 | Dec 31, 2024 | €205.23M | – |
| Q4 FY2023 | Dec 31, 2023 | €327.06M | – |
| Q4 FY2022 | Dec 31, 2022 | €75.54M | – |
| Q4 FY2021 | Dec 31, 2021 | €109.23M | – |
See a number that looks wrong?